sumitomo pharma earnings call：To shareholders and investors
To shareholders and investors
Usefulinformation,includingourbusinesses,financialresultsandfuturestrategy,ispresentedheretoprovideyouwithanenhancedunderstandingofthe ...。其他文章還包含有：「PresentationWebcast」、「InvestorRelations(SecurityCode」、「FinancialResults」、「IRCalendar」、「ConferenceCallfor3rdQuarterofFY2022Financial...」、「InvestorRelations」、「Transcript:SumitomoPharmaCo.」、「ConsolidatedFinancialResult...
查看更多 離開網站
PresentationWebcast
https://www.sumitomo-pharma.co
Financial results for FY2019 · May 14, 2020 Investors Meeting Presentation for FY2019（PDF/1,657KB） · Jan. 30, 2020 Q3 FY2019 Conference Call（PDF/1,386KB） · Nov ...
Investor Relations (Security Code
https://www.sumitomo-pharma.co
Posted Conference on Q1 FY2024 Financial Results [Webcast] · Sumitomo Pharma Announces Topline Results from Post-Marketing Clinical Study on TWYMEEG for the ...
Financial Results
https://www.sumitomo-pharma.co
Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2025 [IFRS]. Full Report（16pages）（PDF/209KB）.
IR Calendar
https://www.sumitomo-pharma.co
IR Calendar ; FY2023 · Jan. 31, 2024. 3rd Quarter of FY2023 financial results announcement ; FY2022 · Jan. 31, 2023. 3rd Quarter of FY2022 financial results ...
Conference Call for 3rd Quarter of FY2022 Financial ...
https://www.sumitomo-pharma.co
Conference Call for 3rd Quarter of FY2022 Financial Results Announcement ... in Sumitomo Pharma Food & Chemical Co., Ltd., assuming a closing by ...
Investor Relations
https://www.sumitomo-chem.co.j
FY2024 1st Quarter Financial Results Conference Call. See more · Special Briefing on the Press Release regarding Petro Rabigh. See more · Understanding the ...
Transcript : Sumitomo Pharma Co.
https://www.marketscreener.com
News Sumitomo Pharma Co., Ltd. Transcript : Sumitomo Pharma Co., Ltd., Q3 2024 Earnings Call, Jan 31, 2024.
Consolidated Financial Results for the Year Ended March ...
https://www.sumitomo-pharma.co
Sumitomo Pharma Co., Ltd. (4506). Summary of Consolidated Financial Results for FY2023. 【Attachment Documents】. 1. Summary of Financial ...
Consolidated Financial Results for the Third Quarter of the ...
https://www.sumitomo-pharma.co
Core segment profit decreased owing to a decrease in gross profit on account of a revenue decline. Page 7. -4 -. Sumitomo Pharma Co., Ltd. (4506).